TABLE 4.
Fasting serum NEFAs identified using a two-way mixed-model ANOVA with repeated time points for within-subject effects between high-dose FO supplementation and control (sunflower oil) groups
| Serum FAs | Within-Subject Effects | Between-Subject Effects | ||||||
| F | Pa | Effect Sizeb | Study Power | F | Pa | Effect Sizeb | Study Power | |
| EPA | 8.36 | 0.0020 | 0.39 | 0.99 | 22.2 | 0.0004 | 0.63 | 0.99 |
| [EPA + DHA] | 5.59 | 0.0030 | 0.30 | 0.92 | 19.0 | 0.0010 | 0.59 | 0.98 |
| DHA | 3.54 | 0.023 | 0.21 | 0.74 | 13.1 | 0.0030 | 0.50 | 0.92 |
| Myristic acid | 1.93 | 0.14 | 0.13 | 0.46 | 1.5 | 0.24 | 0.10 | 0.21 |
| Pentadecanoic acid | 1.28 | 0.30 | 0.090 | 0.31 | 0.0 | 0.95 | 0.00 | 0.05 |
| Heptadecanoic acid | 0.28 | 0.84 | 0.020 | 0.10 | 0.26 | 0.62 | 0.02 | 0.080 |
| Linoleic acid | 0.34 | 0.80 | 0.030 | 0.11 | 1.5 | 0.24 | 0.11 | 0.21 |
| Oleic acid | 0.50 | 0.68 | 0.040 | 0.13 | 1.9 | 0.19 | 0.13 | 0.25 |
a
Mixed-model ANOVA significant at the P < 0.001 level for EPA and DHA only for within- and between-subject effects, where data sphericity was assumed/satisfied using Mauchly’s test of sphericity.
b
Based on partial eta squared.